• FirefoxInstall the new Firefox »
  •  Dow Down0.45% Nasdaq Down0.49%

    Nektar Therapeutics (NKTR)

    -NasdaqGS
    13.07 Up 0.09(0.69%) Feb 27, 4:00PM EST
    |After Hours : 13.07 Down 0.00 (0.01%) Feb 27, 4:38PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue 132,871   28,513   19,771   31,146  
    Cost of Revenue9,220  5,108  7,907  8,960  
    Gross Profit 123,651   23,405   11,864   22,186  
    Operating Expenses
    Research Development34,200  36,702  38,338  48,248  
    Selling General and Administrative9,130  9,619  9,928  9,832  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 80,321   (22,916) (36,402) (35,894)
    Income from Continuing Operations
    Total Other Income/Expenses Net127  96  312  100  
    Earnings Before Interest And Taxes80,448  (22,820)(36,090)(35,794)
    Interest Expense9,595  9,622  9,920  10,230  
    Income Before Tax70,853  (32,442)(46,010)(46,024)
    Income Tax Expense248  195  191  1,635  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops70,605  (32,637)(46,201)(47,659)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 70,605   (32,637) (46,201) (47,659)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 70,605   (32,637) (46,201) (47,659)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.